Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy
Bijun Zeng, Anton PJ Middelberg, Adrian Gemiarto, Kelli MacDonald, Alan G Baxter, Meghna Talekar, Davide Moi, Kirsteen M Tullett, Irina Caminschi, Mireille H Lahoud, Roberta Mazzieri, Riccardo Dolcetti, Ranjeny Thomas
Journal of Clinical Investigation | AMER SOC CLINICAL INVESTIGATION INC | Published : 2018
Awarded by National Health and Medical Research Council (NHMRC)
The work was supported by National Health and Medical Research Council (NHMRC) grants 1083192, 1082665, and 1083747, and by a grant from the Australian Skin and Skin Cancer Centre. RT was supported by Arthritis Queensland and an NHMRC Research Fellowship. ML and IC were supported by a Bill and Janina Amiet Fellowship. We thank Christian Engwerda (QIMR Berghofer) and Ian Frazer (Diamantina Institute, University of Queensland) for supplying mice and Hendrik Nel for technical assistance.